Search by Drug Name or NDC
NDC 50268-0189-15 Cyproheptadine Hydrochloride 4 mg/1 Details
Cyproheptadine Hydrochloride 4 mg/1
Cyproheptadine Hydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvPAK. The primary component is CYPROHEPTADINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Cyproheptadine relieves red, irritated, itchy, watery eyes; sneezing; and runny nose caused by allergies, irritants in the air, and hay fever. It may also be used to relieve the itching of allergic skin conditions, and to treat hives, including hives caused by exposure to cold temperatures and by rubbing the skin. Cyproheptadine is also sometimes used to treat allergic reactions in people who have received blood products as part of medical treatment and to treat life-threatening allergic reactions after the symptoms have been brought under control with other medications. Cyproheptadine will help relieve symptoms but will not treat the cause of symptoms or speed recovery. Cyproheptadine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.
Related Packages: 50268-0189-15Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Cyproheptadine
Product Information
| NDC | 50268-0189 |
|---|---|
| Product ID | 50268-189_0e85fd80-0968-6f07-e063-6394a90a0555 |
| Associated GPIs | 41500020100305 |
| GCN Sequence Number | 004011 |
| GCN Sequence Number Description | cyproheptadine HCl TABLET 4 MG ORAL |
| HIC3 | Z2P |
| HIC3 Description | ANTIHISTAMINES - 1ST GENERATION |
| GCN | 15811 |
| HICL Sequence Number | 001672 |
| HICL Sequence Number Description | CYPROHEPTADINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Cyproheptadine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Cyproheptadine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 4 |
| Active Ingredient Units | mg/1 |
| Substance Name | CYPROHEPTADINE HYDROCHLORIDE |
| Labeler Name | AvPAK |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207555 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 50268-0189-15 (50268018915)
| NDC Package Code | 50268-189-15 |
|---|---|
| Billing NDC | 50268018915 |
| Package | 50 BLISTER PACK in 1 BOX (50268-189-15) / 1 TABLET in 1 BLISTER PACK (50268-189-11) |
| Marketing Start Date | 2021-03-22 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.10716 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | CYPROHEPTADINE 4 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |